-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Germline POT1 Mutation Predisposing to Pediatric Burkitt Leukemia

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: Germline Predisposition That Intersects With Lymphoid Malignancies, Solid Tumors, and DNA Repair Pathways
Friday, December 8, 2023, 3:37 PM-4:18 PM

Harry Layton Lesmana, MD

Department of Pediatric Hematology, Oncology and BMT, Cleveland Clinic, Cleveland, OH

Disclosures: Layton Lesmana: Pharming: Consultancy.

See more of: Germline Predisposition That Intersects With Lymphoid Malignancies, Solid Tumors, and DNA Repair Pathways
See more of: Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation >>